公式動画ピックアップ
AAPL
ADBE
ADSK
AIG
AMGN
AMZN
BABA
BAC
BL
BOX
C
CHGG
CLDR
COKE
COUP
CRM
CROX
DDOG
DELL
DIS
DOCU
DOMO
ESTC
F
FIVN
GILD
GRUB
GS
GSK
H
HD
HON
HPE
HSBC
IBM
INST
INTC
INTU
IRBT
JCOM
JNJ
JPM
LLY
LMT
M
MA
MCD
MDB
MGM
MMM
MSFT
MSI
NCR
NEM
NEWR
NFLX
NKE
NOW
NTNX
NVDA
NYT
OKTA
ORCL
PD
PG
PLAN
PS
RHT
RNG
SAP
SBUX
SHOP
SMAR
SPLK
SQ
TDOC
TEAM
TSLA
TWOU
TWTR
TXN
UA
UAL
UL
UTX
V
VEEV
VZ
WDAY
WFC
WK
WMT
WORK
YELP
ZEN
ZM
ZS
ZUO
公式動画＆関連する動画 [Season 2 Episode 9: Are We Too Risk Averse in Clinical Research?]
This week, Richard Young speaks to Ken Getz, executive director and research professor at Tufts Center for the Study of Drug Development. Already well-known in our industry for his pioneering research on protocol design complexity and trial efficiency, Ken’s most recent study found that the average number of amendments per protocol increased by almost 60% over the past seven years. In this episode, Richard and Ken debate whether clinical research is striking the right balance in its approach to risk and innovation, the problem-solving role played by sites, and CISCRP’s work to improve public trust in scientific advances.
Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.
Spotify: https://lnkd.in/e5pJ7saP
Youtube: https://bit.ly/3quY9FY
Apple Podcasts: https://lnkd.in/efMTxybk
Veeva website: https://go.veeva.com/3RYLkmu
439
2